The global point of care diagnostics market size is expected to reach USD 68.5 billion by 2030, registering a CAGR of 5.8% from 2025 to 2030, according to a new report by Grand View Research, Inc. The ...

An alternative to laboratory testing is Point-of-Care-Testing (POCT), medical testing that occurs outside of a clinical laboratory and near the patient. Potential advantages of POCT include reduction ...

Q1 revenues increased 412% year over year, driven by AI Nose productsDelivers strong turnaround from gross loss to gross profit in Q1AI Nose gains traction beyond healthcare with strategic partnership ...

Some of the key drivers for market growth are the rising prevalence of chronic conditions Market, rising geriatric population, and technology advance ...

The Europe in vitro diagnostics (IVD) market has showcased significant growth, with its valuation increasing from $13,825 million in 2019 to an anticipated $18,647 million by 2027. This report ...

Health Canada has granted approval for NanoSpeed Diagnostics’ Test4D Serum, designed to identify vitamin D levels in blood serum. This development follows the ISO 13485 MDSAP certification of ...

ORLANDO, FL / ACCESS Newswire / May 5, 2025 / RedChip Companies aired interviews with Atossa Therapeutics, Inc. (Nasdaq:ATOS) and Ainos, Inc. (Nasdaq:AIMD) on the RedChip Small Stocks, Big Money show, ...